Gender-Specific Role of p202 in Lupus Susceptibility
Gender-Specific Role of p202 in Lupus Susceptibility
批准号:
7192486
负责人:
DIVAKER CHOUBEY
金额:
$29.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-01 至 2009-02-28
关键词:
AffectAgeAmino AcidsApoptosisAutoimmune DiseasesBindingBiological AssayCD4 Positive T LymphocytesCell Cycle ProgressionCell DeathCellsCessation of lifeCongenic MiceDefectDevelopmentDiseaseDown-RegulationE2F1 geneEstrogen ReceptorsEstrogensFemaleFemale of child bearing ageGenderGene ExpressionGene TargetingGenerationsGenesGeneticGenetic PolymorphismGenetic TranscriptionGonadal Steroid HormonesHereditary DiseaseHumanImmune systemInterferon Type IInterferon-alphaInterferonsInterleukin-6Longitudinal StudiesLupusLupus ErythematosusMediatingMessenger RNAMolecularMouse StrainsMusPhosphoproteinsPhosphorylationPlacebosPredispositionProline-Rich DomainPromoter RegionsProteinsRegulationRepressionResistanceRoleSex BiasSplenocyteStructureSusceptibility GeneSystemic Lupus ErythematosusT-LymphocyteTP53 geneTestingTranscriptional ActivationUp-Regulationbasechromatin immunoprecipitationcongenicdesignmalemouse model
中文摘要
描述(由申请人提供):系统性红斑狼疮(SLE)是一种主要影响育龄妇女的自身免疫性疾病。虽然性激素与该病发展的性别偏见有关,但分子机制仍不清楚。SLE易感基因的表达受性激素调控,阐明其作用对了解疾病的发展具有重要意义。B6的特性。Nba2狼疮易感基因小鼠和功能分析揭示了干扰素(IFN)可激活的Ifi202基因在SLE易感性中的未知作用。拟议研究的主要目的是了解某些狼疮易感小鼠株中Ifi202基因的性别特异性表达增加,并确定编码磷酸化蛋白p202在狼疮易感性发展中的作用。蛋白p202 (52-kDa)是一种可诱导(可被i型IFN和白细胞介素-6诱导)的转录调节剂,具有抑制细胞周期进程和凋亡的能力。基于我们的初步和其他观察,我们假设性别特异性和遗传因素有助于某些狼疮易感小鼠品系中p202表达的增加。此外,我们假设p202通过抑制促凋亡因子(如E2F和p53)的转录活性,提高B细胞和T细胞的凋亡阈值,从而促进狼疮易感性。目的1:确定性别特异性和遗传因素如何促进p202的表达增加。我们将比较年龄匹配的雄性和雌性小鼠(B6、NZB和B6)中Ifi202 mRNA和蛋白的表达。Nba2株小鼠)、雄性和切除卵巢的雌性小鼠,以及雌激素或安慰剂治疗的切除卵巢的雄性和雌性小鼠。此外,我们将确定(i)雌激素(E2)水平如何通过雌激素受体激活Ifi202的转录;(ii) e2介导的转录后机制(如Ifi202 mRNA和蛋白稳定)是否有助于p202的上调;(iii) p202的核质分布及其磷酸化是否取决于性别、i型干扰素(α和β)或白细胞介素-6的水平。目的2:研究(来自雄性和雌性小鼠)脾细胞中p202水平的升高是否与E2F (E2F1和E2F2)转录活性的抑制、E2F靶基因表达的下调以及激活诱导的CD4+ T细胞死亡缺陷相关。目的3:阐明脾细胞(来自雄性和雌性小鼠)中p202表达增加抑制p53介导的转录激活和基因抑制以及p53介导的细胞凋亡的分子机制。意义:我们的研究将在狼疮小鼠模型中确定免疫系统细胞中p202的性别特异性表达增加对狼疮易感性的分子机制。
英文摘要
DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) is an autoimmune disease that predominantly affects women of childbearing age. Although sex hormones have been implicated in gender bias of the development of this disease, molecular mechanisms remain largely unknown. Elucidation of the role of SLE susceptibility genes, expression of which is regulated by sex hormones, is important to understand the development of the disease. Characterization of the B6.Nba2 lupus prone congenic mice and functional analysis has revealed a previously unknown role for the interferon (IFN)-activatable Ifi202 gene in SLE susceptibility. The major objectives of the proposed studies are to understand the gender-specific increased expression of Ifi202 gene in certain lupus prone strains of mice and to define the role of the encoded phosphoprotein, p202, in the development of lupus susceptibility. The protein p202 (52-kDa) is an inducible (inducible by type-I IFN and interleukin-6) transcriptional modulator with demonstrated ability to inhibit cell cycle progression and apoptosis. Based on our preliminary and other observations, we hypothesize that gender-specific and genetic factors contribute to increased expression of p202 in certain lupus-prone strains of mice. Moreover, we postulate that p202 contributes to lupus susceptibility by increasing the threshold for apoptosis in B and T cells by inhibiting the transcriptional activity of proapoptotic factors, such as E2F and p53. Aim #1: To determine how gender-specific and genetic factors contribute to increased expression of p202. We will compare expression of Ifi202 mRNA and protein between age-matched male and female mice (B6, NZB, and B6.Nba2 strains of mice), male and ovariectomized female mice, and estrogen or placebo treated orchiectomized male and female mice. Additionally, we will determine (i) how estrogen (E2) levels through estrogen receptor activate the transcription of the Ifi202; (ii) whether E2-mediated posttranscriptional mechanisms, such as Ifi202 mRNA and protein stabilization, contribute to up-regulation of p202; and (iii) whether nucleocytoplasmic distribution of p202 and its phosphorylation depend on the gender, levels of type-I interferons (alpha and beta), or interleukin-6. Aim #2: To investigate whether increased levels of p202 in splenocytes (from male and female mice) correlate with inhibition of the transcriptional activity of E2Fs (E2F1 and E2F2), down-regulation of the expression of the E2F target genes, and defects in activation-induced cell death of CD4+ T cells. Aim #3: To elucidate the molecular mechanisms by which increased expression of p202 in splenocytes (from male and female mice) inhibits p53-mediated transcriptional activation and repression of genes, and p53-mediated apoptosis. Significance: Our studies will identify molecular mechanisms by which gender-specific increased expression of p202 in cells of the immune system contributes to lupus susceptibility in a mouse model of lupus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8795672
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8481178
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8696826
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8329212
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of Aim2 in Inflammation and Autoimmunity
-
批准号:8317789
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7613399
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7415050
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7091879
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7438836
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7485797
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7914357
-
项目类别:
-
资助金额:$36.1万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7068073
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7740619
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:6959452
-
项目类别:
-
资助金额:$25.25万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI 16 in Cellular Senescence and Aging
-
批准号:6614227
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2003
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2443212
-
项目类别:
-
资助金额:$9.95万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2825892
-
项目类别:
-
资助金额:$11.27万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:6172809
-
项目类别:
-
资助金额:$11.72万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2113102
-
项目类别:
-
资助金额:$9.56万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2733191
-
项目类别:
-
资助金额:$10.83万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: